Introduction
Ligaments are tight bands of dense connective tissue which connect bones, stabilize joints and help guide joint motion. The majority of evidence suggests that ligaments are important mechanical stabilizers of joints, augmenting muscle-tendon forces in their control of joint movements. 1 Ligament injuries are extremely common 2 and significant joint instability due to loss of ligament function sometimes predispose to the development of degenerative arthritis. 3 The healing potential of ligaments, however, is poor. It takes longer for ligaments to heal than other connective tissues. The healed ligament is biologically scar-like and is biomechanically inferior to normal ligament tissue. [4] [5] [6] [7] At present, despite a variety of acute treatments including surgical repairs, grafting and physiotherapy, the optimal conditions for the healing of ligaments have still not been established. Further, even the 'functional success' of treatment does not appear to be preventing osteoarthritis. 8 Therefore, the establishment of a novel therapeutic approach for accelerating and improving ligament repair is needed.
Several polypeptide growth factors and cytokines have been shown to play essential roles in connective tissue healing. Recent investigations suggest that plateletderived growth factor (PDGF) mediates many processes required for tissue repair, including chemotaxis (monocytes, neutrophils, fibroblasts); proliferation (fibroblasts, smooth muscle cells, wound capillary endothelial cells); induction of extracellular matrix (fibronectin, hyaluronic acid); and of metalloproteinases required for angiogenesis and wound remodeling. 9, 10 Furthermore, in vivo application of PDGF to the incised skin wound has been demonstrated to enhance the deposition of extracellular matrix to the wound during the healing process. [11] [12] [13] [14] [15] Based on these findings, PDGF could be regarded as a promising molecule for accelerating and improving the healing of connective tissues, including ligaments.
In an attempt to optimize the presence of specific growth factors in healing joint structures, gene transfer has received attention for its potential biological manipulation of healing. 16 With this concept, we have recently developed an in vivo gene transfer model into healing rat patellar ligament using hemagglutinating virus of Japan-conjugated liposomes and have shown that a reporter gene is expressed in the healing ligament for around 4 weeks after injection. 17 In this study, we investigated the early biological effect of PDGF-B gene introduction on the healing process of the rat patellar ligament, using this model.
Results
One week after gene transfer, PDGF-B was diffusely expressed by the cells in the ligament-injured site as well as in the adjacent ligament substance in both the PDGFintroduced and the control ligaments (Figure 1 ), however, laminin staining showed significantly more hypervascularity around the wound in the PDGF-introduced group compared with the control group (Figures 2 and  7 ). Masson's Trichrome (M-T)-staining showed that PDGF-introduced wound had formed more disorganized collagen matrix with more intense blue staining (Figure 3 ). There was no significant difference in the expression of collagen I between the PDGF-introduced wound and the control wound ( Figure 8 ). At 4 weeks, PDGF-B staining was localized to the wound site in the control group ( Figure 4B ), while intense staining for PDGF-B was detected not only in the wound, but also in the adjacent old ligament substance in the PDGF-introduced group ( Figure 4A ). No significant difference in vascularity was observed by laminin immunostaining in both the PDGF-introduced and the controlled wounds ( Figure 7 ). Collagen deposition, however, increased in the PDGF-introduced wound. M-T staining was more intense in the PDGF-introduced wound than in the control wound ( Figure 5 ). Likewise, the collagen I immunostained area was significantly larger in the PDGF-introduced wound (Figures 6 and 8 ). On day 56, PDGF staining in the adjacent ligament area disappeared in the PDGF-introduced group and the staining was localized to some cells in the wound as in the control group (data not shown). There was no significant difference in the area stained for laminin or collagen I in the wounds between the two groups ( Figures 7 and 8) .
Discussion
This study has demonstrated that in vivo introduction of the PDGF-B gene into a patellar ligament wound results in overexpression of PDGF-B around the wound for over 28 days after transfection. Our previous study showed that efficiency of transfection at 4 weeks in this model is 2%. 17 The effect of gene transfer was, however, more than what was expected from the transfection efficiency data; PDGF-B was overexpressed in the extensive area of wound and adjacent ligament substance on day 28 (see Figure 4) . Therefore, it could be interpreted that the overexpression of PDGF-B by the small number of transfected cells may activate a cascade of PDGF-B production throughout the wound.
Enhanced angiogenesis was observed around the PDGF-introduced wound on day 7. This change appears reasonable in consideration of the previous observation that PDGF promotes the proliferation of smooth muscle cells and of wound capillary endothelial cells. 9, 10 As previously reported that PDGF-B expresses extensively in the rabbit medial collateral ligament wound of the knee around day 7 after injury, 18 PDGF-B staining was strong throughout the control wound (without gene transfer) at 1 week. Therefore, it was difficult to evaluate the effect of gene transfer on the PDGF-B expression in the wound by immunohistochemistry at this point. The enhanced angiogenesis, however, suggests the overexpression of PDGF-B in the early wound. At 4 weeks, angiogenesis was reduced to normal level. A recent collagen gel culture study indicates that extracellular matrix organization alters PDGF regulation of fibroblast integrins, 19 which are a family of cell surface receptors for the extracellular matrix and are regarded as key molecules for angiogenesis. 20 In the present study, there was a significant increase of collagen deposition and rearrangement of collagen matrix (compare Figures 3 and 5 ) in the day 28 wound compared with that on day 7. Therefore, it appears that increased deposition and realignment of collagen matrix may have suppressed the action of PDGF to angiogenesis in the wound.
What is most significant about the results of this study is the enhanced matrix deposition in the PDGF-transferred healing ligament wound. Since the expression of proteoglycans is elevated in the early ligament wound, 21 the synthesis and degradation of these proteins with the glycosaminoglycan (GAG) chains might affect the accessibility of collagen I antibody to its epitopes. To confirm the possibility, we performed alcian blue staining (at pH 2.5) in the control and the PDGF-transferred wound at 4 weeks for the detection of the hyaluronic acid and sulfated GAGs, but there was no detectable difference in staining intensity. Further, we treated the sections with Chondroitinase ABC (1 unit/ml in Tris-acetate pH 7.2 at 37°C for 20 min) before immunolabeling for collagen I to enhance the permeability of the tissues (by the removal of GAG chains). However, no enhancement of collagen I fluorescence was observed (data not shown). Therefore, we interpret that the difference in collagen I staining between the control and the PDGF-treated wounds is mainly due to the difference in the amount of collagen deposition within the wounds. Thus, this study could be the first substantial demonstration of enhanced matrix deposition in the early stage of ligament healing. PDGF introduction resulted in promoted synthesis of collagen I over 4 weeks. There has been no in vitro study demonstrating the direct effect of PDGF on the synthesis of collagen I, while it is known that PDGF stimulates macrophages to produce TGF-␤1, 12, 22 which stimulates collagen formation. 23 Collectively, some stimulating factors of matrix synthesis, like TGF-␤1, could be simultaneously overexpressed in the PDGF gene-transferred healing ligament. There was no more significant collagen I deposition in the gene transferred wound at 8 weeks by our semiquantitative morphological analysis, however, it should be noted that the amount of collagen deposition in the gene transferred wound came up to a comparable amount with that of the control wound 4 weeks earlier. This could be interpreted as the acceleration of ligament healing by gene transfer.
In conclusion, our present study confirms that, despite the fact that not all cells express the foreign gene, 17 local expression of key molecules can be altered with our gene transfer technique. Further, transient elevation of a growth factor, PDGF-B, leads to enhanced angiogenesis and collagen synthesis in the healing ligament over 4 weeks after transfection. These results suggest the possible application of this gene therapy technique for accelerating soft tissue repair.
Materials and methods

Construction of plasmid
The pAct-CAT plasmid, originally constructed by N Davidson, contains bacterial chloramphenicol acetyltransferase (CAT) gene with the chicken ␤-actin promoter gene, the SV40 early promoter on the 5′ end and SV40 splice and poly A sequences on the 3′ end. 24 pAct-PDGF was kindly provided by Dr Enyu Imai (Osaka University), and was constructed by exchanging the coding region of CAT gene (HindIII/HpaI fragment of pAct-CAT) from pAct-CAT with the BamHI fragment containing the complete coding region of PDGF-B cDNA from pSM-1.
25,26 pSM-1 was supplied by American Type Culture Collection, Rockville, MD, USA.
Preparation of haemaggulutinating virus of Japan (HVJ)-liposomes HVJ-liposomes were prepared as described previously. 27, 28 Briefly, 10 mg of dried lipid mixture (phosphatidylcholine, phosphatidylserine and cholesterol) was hydrated in balanced salt solution (BSS; 140 mm NaCl, 5.4 mm KCl, 10 mm Tris-HCl, pH 7.5) containing plasmid DNA and high mobility group (HMG)-1 nuclear protein. The mixture was agitated and sonicated for preparation of unilamellar liposomes. The liposomes were then incubated with HVJ, which had been inactivated with ultraviolet irradiation, to allow formation of HVJ-liposomes. Thus, plasmid DNA and HMG-1 are capsulated into the liposomes with inactivated HVJ spikes on their surfaces.
Surgical model and injection of HVJ-liposomes
The medial half of the patellar ligaments of 12, 14-weekold male Wistar rats was cut transversely at the center portion with a scalpel. HVJ-liposomes containing PDGF-B DNA in a total volume of 10-15 l were injected directly into the wound site and were also pooled into the fascial pocket (the pocket of the periligamentous tissue) 5 days following the injury by using a 33-gauge needle (Hamilton, NV, USA). 17 For the control study, HVJ-liposomes instilled in BSS were injected into the similarly injured region in the contralateral knee. The animals were allowed to return to normal cage activity and were killed at 1, 4 and 8 weeks following injection. Four rats were killed on each of these days.
Preparation of histological sections
Immediately after death, the whole length of the patellar ligament was excised and was fixed in 4% paraformaldehyde in phosphate buffer (pH 7.4) for 3 days at 4°C. Following fixation, cryosections (6-m thick) of the whole length of the ligaments were prepared for histological analysis and stored at −20°C until they were used for immunohistochemistry and for histochemistry. Three sections (from superficial, mid and deep portions of the wound) from each wound were analyzed for these studies.
Immunohistochemistry
For the indirect immunofluorescence study, cryosections were incubated with the primary antibody diluted in Tris-buffered saline (TBS; 20 mm Tris-HCl, 0.9% NaCl, pH 7.6) overnight at room temperature, after incubation with fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit IgG (Zymed, CA, USA), for 3 h at room temperature. Normal rabbit IgG (Sigma, St Louis, MO, USA), instead of the primary antibody, was used for the control experiment. The sections were examined with a fluorescent microscope (Axiophoto; Zeiss, Jena, Germany).
PDGF expression in the healing ligament was evaluated by the immunostaining for PDGF-B. Polyclonal antibody to human PDGF-BB, that specifically crossreacts Bchain of rat PDGF (Genzyme, MA, USA), was used as the primary antibody. To study the angiogenic response of healing ligament, the sections were immunostained for laminin. 29 Polyclonal antibody to rat laminin (Chemicon, Harrow, UK) was used as the primary antibody. Collagen deposition in the wound site was evaluated by Masson's Trichrome staining as well as collagen type I immunohistochemistry. Polyclonal antibody to rat collagen I (Chemicon) was used as the primary antibody for immunohistochemistry.
Semiquantification of immunohistochemistry
In order to semiquantify the expression of laminin and collagen I within the gene-transferred (n = 12) and the control wound (n = 12), the VIDAS automatic image analysis system (Kontron Elektronik, Mü nchen, Germany) was utilized. The fluorescence for laminin and collagen I in the examined field was discriminated by the system, and the area was given as a percentage of the total field area. An average of the six fields (×200) from three sections (superficial, mid and deep portion), covering the whole wound area in each section, was then calculated to give an average percentage area of the protein expression in each animal. An unpaired t test was used to compare the gene-transferred and the control group. An alpha level of 0.05 was used.
